Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01759407Phase 2Terminated
A Phase 2 trial of ropivacaine in femoral fracture, sponsored by Nationwide Children's Hospital. Started May 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01759407.